Differentiation Agents
Differentiation Agent is a type of antineoplastic drug that induces malignant cells to mature into more specialized, functionally normal cells by modulating gene expression and cellular development pathways, thereby inhibiting proliferation and promoting terminal differentiation instead of causing direct cytotoxicity.
188
Publications
7.8K
Citations
839
Authors
240
Institutions
Publications per year
2017–2026
14
Variants
Differentiation-inducing Agents
Parents
188
1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60)
Hirofumi Tanaka, E Abe, Chisato Miyaura et al. · Biochemical Journal · 1982 · 393 citations · Full text
Steven Collins, Amos Bodner, R. C. Ting et al. · International Journal of Cancer · 1980 · 350 citations
Medicine, Oncology, Pharmacology +11
1–5 of 188
839
7
h-index
4
h-index
Rutgers, The State University of New Jersey, United States
3 publications · 90 citations
3
h-index
3
h-index
3
h-index
1–5 of 839
240
Saitama Cancer Center
Saitama, Japan
8 h-index
20 publications
443 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
7 h-index
25 publications
2.5K citations
Memorial Sloan Kettering Cancer Center
New York, United States
5 h-index
14 publications
4.4K citations
National Cancer Institute
Bethesda, United States
5 h-index
6 publications
776 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
4 h-index
7 publications
129 citations

University of Maryland, Baltimore
Baltimore, United States
4 h-index
8 publications
439 citations

Cornell University
Ithaca, United States
4 h-index
18 publications
683 citations

Weizmann Institute of Science
Rehovot, Israel
3 h-index
4 publications
237 citations
1–8 of 240
Repository · 55 publications · 2.4K citations
27
h-index
4 publications · 170 citations
4
h-index
4 publications · 95 citations
4
h-index
4 publications · 140 citations
4
h-index
4 publications · 559 citations
4
h-index
1–5